The Fraser Institute

The Fraser Institute

September 24, 2013 08:33 ET

Media Advisory: How Can Canada Reduce Wait Times for New Medicines? New Study Coming Wednesday, September 25

CALGARY, ALBERTA--(Marketwired - Sept. 24, 2013) - The Fraser Institute will release a new study Wednesday, September 25 outlining how Canadians could gain faster access to new medicines that could help alleviate pain and suffering stemming from major illnesses.

Many new medicines that could help Canadians suffering from life-threatening diseases are often unavailable because they have yet to be approved by Health Canada. Meanwhile, these same medicines are often already widely available in the European Union or the United States.

A news release with additional information will be issued via Marketwired at 6:30 a.m. (Eastern) on Wednesday, September 25.

The full report will also be available as a free PDF download at www.fraserinstitute.org.

Follow the Fraser Institute on Twitter and Facebook

The Fraser Institute is an independent Canadian public policy research and educational organization with offices in Vancouver, Calgary, Toronto, and Montreal and ties to a global network of 86 think-tanks. Its mission is to measure, study, and communicate the impact of competitive markets and government intervention on the welfare of individuals. To protect the Institute's independence, it does not accept grants from governments or contracts for research. Visit www.fraserinstitute.org

Contact Information

  • Nadeem Esmail
    Director of Health Policy Studies
    Fraser Institute
    (403) 216-7175 ext. 422
    nadeem.esmail@fraserinstitute.org
    @NadeemEsmail

    Dean Pelkey
    Director of Communications
    Fraser Institute
    (604) 714-4582